What is Alexandria Real Estate Equities Inc?
an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world.
ARE · Verdict
Limited reward · elevated risk
ARE has limited near-term tailwinds — balance sheet and growth weigh on the model output.
Based on 88% data coverage
ARE · Verdict
Net debt/EBITDA 33.9×
Revenue +4.9% CAGR
Below average
P/E 16.7× · PEG 3.24
-48% net margin · -4% ROE
Model-based scoring. For information only — not financial advice.
an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. The company is listed on the NYSE in USA, operating in the Real Estate sector, with a market capitalisation of 7.15B.
The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.